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disease in children. Hence, our objective was to measure global DNA methylation level by ELISA method in children with TB disease matched with healthy controls.
Methods

Ethical approval
This study was conducted in the Department of Paediatrics of a tertiary care referral hospital during the period of December 2014 to December 2017. The study was approved by the Institute Scientific Advisory Committee and Human Ethics Committees.
Patients and blood collection
Since no similar studies had been done in the past, a sample size of convenience was taken. Forty-three (n=43) children with TB disease and Thirty-three (n=33) healthy children were enrolled in this study after written informed consent.
The inclusion criteria for both pulmonary TB (PTB) and extra-PTB (EPTB) infections included (<14 years, both genders): GeneXpert positive, smear positive, culture positive, chest X-ray positive, skin test positive, and clinical findings of TB infection.
The inclusion criteria for healthy donors (<14 years, both genders) included no signs of TB and other infections, HIV negative, no surgical procedures underwent recently, asthma, and no other lung problems.
Genomic DNA isolation
Blood was collected from both groups and FavorPrep Genomic DNA Mini Kit (Favorgen, Taiwan) was used according to the manufacturer's instructions. Briefly, 300 μL of whole blood was used to isolate genomic DNA with elution volume of 50 μL and Nanodrop 2000 spectrophotometer (Thermo Scientific, USA) used to measure the concentration of genomic DNA.
5-mC DNA methylation quantification
The concentration of 5-methylcytosine (5-mC) in genomic DNA was quantified using 5-mC DNA ELISA kit (Zymo Research, USA) according to manufacturer's instructions. Fully methylated DNA (100% M) and fully unmethylated DNA (100% U) were used as positive and negative controls, respectively. The concentrations of 0%, 5%, 10%, 25%, 50%, 75%, and 100% of methylation were prepared [Supplementary Table 1 ] by mixing of both M and U DNA to prepare a standard curve.
Briefly, 100 ng of genomic DNA was added in a PCR tube and made up to 100 μL of total volume with 5-mC coating buffer and denatured by heating at 98°C for 5 min in a thermal cycler (Eppendorf Mastercycler, Germany) and transferred immediately to ice for 10 min. Denatured DNA samples were added to 96-well microtiter plate covered with foil and incubated at 37°C for 1 h. Wells were washed three times with 200 μL of 5-mC ELISA buffer and 200 μL of 5-mC ELISA buffer was added to each well and incubated at 37°C for 30 min.
Anti-5-methylcytosine and secondary antibody mixture were prepared in the ratio of 1:2:2000 in 5-mC ELISA buffer and 100 μL of this antibody mixture was added to each well and covered with foil and incubated at 37°C for 1 h.
Wells were washed three times with 200 μL of 5-mC ELISA buffer and 100 μL horseradish peroxidase developer solution was added. The plate was kept in room temperature for 60 min for color development. Absorbance reading was measured at 450 nm using ELISA plate reader (Robonik Readwell Touch 3·400A, India). Triplicates were performed to each sample to validate the results.
Statistical analysis
Categorical data were expressed as numbers and percentages. Percentage (%) of genomic DNA methylation level was expressed in the median with interquartile range (IQR) and Mann-Whitney t-test was performed to evaluate the difference in % 5-mC between cases and controls. Receiver operating curve (ROC) analysis was performed to evaluate the cutoff value of % 5-mC in the study groups. All statistical analyses were carried out in IBM SPSS Statistics for Windows, version 19 (IBM Corp., Armonk, N.Y., USA) and MS-Excel at 95% confidence interval with P < 0.05 was considered as statistically significant.
results
TB infected children included in this study settings were homogenous population with respect to demographic characteristics [ Table 1 ], and genomic DNA methylation level was analyzed between cases and healthy controls.
Among the 43 cases, 20 (46.5%) were PTB and 23 (53.5%) were EPTB and frequency of EPTB cases enrolled in this study represented in Figure 1 .
Significant difference in percentage of global DNA methylation level was found between cases (n = 43) and controls (n = 33) and difference in percentage of global DNA methylation level expressed in median within cases 6.25% (IQR, 2.5%-10%) and in controls 25% (IQR, 12.5%-25%) (P < 0.0001) [ Figure 2a ]. The median distribution of percentage of global DNA methylation among different diagnostic procedures is represented in Figure 2b . No significant difference in percentage of global DNA methylation level was found between PTB and EPTB included in this study in relation with clinical outcome [ Table 2 ].
Significant difference in percentage of global DNA methylation level was found in GeneXpert-positive cases (P < 0.01) and no significant in difference in percentage of global DNA methylation level was found in various diagnostic procedures performed for TB cases [ Table 2 ].
Receiver operating curve analysis
ROC analysis showed a cutoff value of 12.5% of genomic DNA methylation between cases and controls, and it can be used as a diagnostic threshold value to differentiate cases from controls, with 75% sensitivity and 84% specificity (P < 0.0001) [ Figure 3 ].
ROC analysis for GeneXpert positive cases with a cutoff value of 6.2% of genomic DNA methylation showed the diagnostic value of 5-mC quantification analysis in accordance with GeneXpert procedure to promptly diagnose children with TB disease with sensitivity 69% and specificity 66% P < 0.01 [ Figure 4 ].
dIscussIon
DNA methylation is a wide studied epigenetic mechanism in a variety of diseases and plays substantial role in several biological processes such as regulating gene expression, organization of chromatin, chromosomal stability, genome imprinting, and homologous recombination. [6, 9, 10] Most of the CpG sites and CpG islands are unmethylated, and its associated genes found to be expressed in a healthy individual genome. [6, 9, 11] Conversely, discrete CpG sites are found to be mostly methylated that impacts the repression of gene-specific loci. Notably, unusual loss in gene-specific methylation and manifestation of global hypomethylation possibly lead to overexpression of genes that are contributing to disease progression. [11] Several reports suggested that DNA methylation is the driven force behind reshaping host epigenome under TB infection and many immune defense genes undergone changes in its expression. [12, 13] Global hypermethylation shuts down immune defense genes and global hypomethylation activates immunosuppressive genes to contribute disease progression in host. [6, 9, 14] The balance between hyper-and hypomethylation is a crucial checkpoint for host to activate or suppress appropriate immune response against infection.
Tubercle bacilli modulates host transcriptional machinery to avert host immune response to ascertain its infection further. [12] The innate immunity when combines with active, adaptive cell-mediated immunity shows higher protective effect against TB infection; however, in some cases, it fails and infection progresses into disease. [15, 16] Several factors are determining TB pathogenesis in children, namely, host genetics, mycobacterial virulence factors, malnutrition, and HIV co-infection but undeveloped immune response contributes majorly the high rate of progressive TB in children. [17] Homogenous population of TB cases and healthy controls was enrolled in this study to measure global DNA methylation changes. This study shows the significant hypomethylation among TB cases when compared to healthy controls. The alteration in genomic DNA methylation level among cases and controls indicates that DNA methylation changes that control host immune behavior through underlying gene expression. The hypomethylation in TB patients supports the notion that activation of specific genes that are contributing to diseases progression in TB infected host; [12, 13] otherwise, it may influence several immune response genes to respond against TB disease in children. [12] Clinical features and TB disease with respect to DNA methylation changes do not correlate and there was no significant difference observed. PTB cases have shown higher DNA methylation level when compared to EPTB cases [ Table 2 ]; however, it fails to meet diagnostic standards. Various diagnostic procedures were included to recruit TB cases and out of all GeneXpert is the standard method for the diagnosis of TB infection in adults and pediatric populations. There was a significant difference in percentage of DNA methylation level was observed among GeneXpert-positive cases [ Table 2 ].
No variation in global DNA methylation level was observed among study populations with respect to demographic characteristics as environmental factors are main confounding factors determining methylation changes. [6] Mycobacteria or mycobacterial products are the key factors behind changes in DNA methylation level. Mycobacterial 19-kDa lipoprotein, early secreted antigenic factor 6, enhanced intracellular survival protein and mannosylated lipoarabinomannan are notable mycobacterial virulence products have regulatory effect on host transcriptional machinery. [6, 9] A cutoff value of 12.5% for genomic DNA methylation was observed to discriminate cases from controls with 75% sensitivity and 84% specificity and Cutoff value of 6.2% with sensitivity 69% and specificity 66% for genomic DNA methylation was observed in GeneXpert-positive cases.
ROC was generated to investigate the accuracy of the 5-mC test performed to differentiate cases from controls. Accuracy was measured by the area under the ROC curve and 1 represents a perfect test and 0.5 indicates a worthless test. [18] The study measured percentage of global DNA methylation among cases and controls that was 0.81 for total cases and 0.76 for GeneXpert-positive cases and these differences are statistically significant. Hence, proved that 5-mC methylation quantification test performed in this study has the ability to differentiate children with TB disease from healthy controls effectively.
conclusIon
Collectively, the study findings show that active global hypomethylation changes could play a substantial role in regulating host immune response against TB disease in children. Furthermore, it indicates the possibility of demethylation in specific repeat elements or genes can be more disease specific. This result ought to be followed by more in-depth DNA methylation analysis at gene loci specific by using bisulfite sequencing or pyrosequencing strategies to comprehend the epigenetic dynamics, how it interacts and regulates host immune response under TB disease.
